FY2025 · period end Dec '25 · from the 10-K filed Feb 12, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $40.55B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-279756 | Jun 23, 2026 | Jun 23, 2026 | Jun 23, 2026 21:08 UTC | EDGAR |
| 8-K | 0001193125-26-271325 | Jun 15, 2026 | Jun 15, 2026 | Jun 15, 2026 21:28 UTC | EDGAR |
| 8-K | 0001193125-26-237130 | May 21, 2026 | May 22, 2026 | May 22, 2026 21:00 UTC | EDGAR |
| 8-K | 0001193125-26-204246 | May 4, 2026 | May 4, 2026 | May 4, 2026 21:00 UTC | EDGAR |
| 8-K | 0001193125-26-187630 | Apr 27, 2026 | Apr 28, 2026 | Apr 28, 2026 21:00 UTC | EDGAR |
| 8-K | 0001138118-26-000013 | Apr 23, 2026 | Apr 23, 2026 | Apr 23, 2026 11:01 UTC | EDGAR |
| 10-Q | 0001138118-26-000015 | Mar 31, 2026 | Apr 23, 2026 | Apr 23, 2026 20:39 UTC | EDGAR |
| 8-K | 0001138118-26-000008 | Mar 24, 2026 | Mar 24, 2026 | Mar 24, 2026 20:32 UTC | EDGAR |
Direct links to SEC EDGAR. CBRE has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Cash Provided by (Used in) Operating Activities·Q2 2020
Major restatementwas$6.1M
Revised up in a 10-Q. Any P/OCF built on the original was 74.9% too high.
Revenues·Q1 2017
Major restatementwas$3B
Revised up in a 10-Q. Any P/S built on the original was 26.4% too high.
Revenues·FY 2016
Major restatementwas$13.1B
Revised up in a 10-K. Any P/S built on the original was 24.7% too high.
Revenues·Q2 2017
Major restatementwas$3.3B
Revised up in a 10-Q. Any P/S built on the original was 24.7% too high.
Revenues·FY 2017
Major restatementwas$14.2B
Revised up in a 10-K. Any P/S built on the original was 23.7% too high.
Revenues·Q3 2017
Major restatementwas$3.5B
Revised up in a 10-Q. Any P/S built on the original was 23.5% too high.
CBRE is not the only one.
See every restatement we've found across the market — or get an alert the next time CBRE revises a number.
Restatements are detected by comparing every vintage of a fact across all of CBRE GROUP, INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CBRE's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling CBRE GROUP, INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CBRE yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CBRE and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $31.95B |
| $30.83B |
| $27.75B |
| Gross Profit | $7.57B | $6.96B | $6.27B | $6.59B | $6.17B |
|---|
| Operating Income | $1.75B | $1.41B | $1.12B | $1.51B | $1.64B |
|---|
| Net Income | $1.16B | $0.97B | $0.99B | $1.41B | $1.84B |
|---|
| EPS (Diluted) | $3.85 | $3.14 | $3.15 | $4.29 | $5.41 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $30.88B | $24.38B | $22.55B | $20.51B | $22.07B |
| Total Liabilities | $21.25B | $15.19B | $13.48B | $11.91B | $12.71B |
| Stockholders' Equity | $9.19B | $9.19B | $9.07B | $8.61B | $9.36B |
| Cash & Equivalents | $1.86B | $1.22B | $1.37B | $1.41B | $2.54B |
| Total Debt | $5.18B | $3.32B | $2.85B | $1.52B | $1.55B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.56B | $1.71B | $0.48B | $1.63B | $2.36B |
| Capital Expenditures | — | — | — | $0.26B | $0.21B |
| Free Cash Flow | — | — | — | $1.37B | $2.15B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 18.7% | 19.4% | 19.6% | 21.4% | 22.2% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% |
| Return on Equity | 12.6% | 10.6% | 11.2% | 15.7% | 22.3% |
| Return on Assets | 4.2% | 4.1% | 4.6% | 6.6% | 9.2% |
| Debt / Equity | 0.56× | 0.36× | 0.31× | 0.18× | 0.17× |
